ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

H VANVEELEN*, PHB WILLEMSE, T TJABBES, MJH SCHWEITZER, DT SLEIJFER

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Scopus)
Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalCancer
Volume58
Issue number1
Publication statusPublished - 1-Jul-1986

Cite this